Bruker (BRKR) Net Cash Flow (2010 - 2026)
Bruker (BRKR) posted Net Cash Flow of -$173.4 million for Q1 2026, down 2688.06% on a QoQ basis from $6.7 million in Q4 2025, and down 1309.76% year-over-year from $14.3 million in Q1 2025.
Bruker (BRKR) Net Cash Flow (2010 - 2026) Analysis & Trends
Bruker's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$173.4 million for Q1 2026.
- Quarterly Net Cash Flow fell 1309.76% year-over-year to -$173.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$88.4 million (up 43.98% YoY) and the FY2025 annual result came in at $72.7 million, up 126.32% from the prior year.
- Net Cash Flow was -$173.4 million for Q1 2026 at Bruker, down from $6.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $201.4 million in Q3 2025 and bottomed at -$241.4 million in Q1 2022.
- A 5-year average of -$55.2 million and a median of -$51.4 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow jumped 882.73% — and 2026, when it plunged 1309.76%.
- Bruker's Net Cash Flow stood at -$13.9 million in 2022, then soared by 882.73% to $108.8 million in 2023, then plunged by 50.0% to $54.4 million in 2024, then slumped by 87.68% to $6.7 million in 2025, then sank by 2688.06% to -$173.4 million in 2026.
- Business Quant data shows BRKR's Net Cash Flow at -$173.4 million in Q1 2026, $6.7 million in Q4 2025, and $201.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | -173.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -173.40 Mn |
| Mar 31, 2026 | -173.40 Mn |
| Dec 31, 2025 | 6.70 Mn |
| Dec 31, 2025 | 6.70 Mn |
| Sep 30, 2025 | 201.40 Mn |
| Sep 30, 2025 | 201.40 Mn |
| Jun 30, 2025 | -123.10 Mn |
| Jun 30, 2025 | -123.10 Mn |
| Mar 31, 2025 | -12.30 Mn |
| Mar 31, 2025 | -12.30 Mn |
| Dec 31, 2024 | 54.40 Mn |
| Dec 31, 2024 | 54.40 Mn |
| Sep 30, 2024 | -31.90 Mn |
| Sep 30, 2024 | -31.90 Mn |
| Jun 30, 2024 | -168.00 Mn |
| Jun 30, 2024 | -168.00 Mn |
| Mar 31, 2024 | -130.70 Mn |
| Mar 31, 2024 | -130.70 Mn |
| Dec 31, 2023 | 108.80 Mn |
| Dec 31, 2023 | 108.80 Mn |